Gemcitabine plus cisplatin versus gemcitabine alone in the treatment of pancreatic cancer: a meta-analysis

被引:0
作者
Guoqing Ouyang
Zhipeng Liu
Shengfu Huang
Qianglong Li
Li Xiong
Xiongying Miao
Yu Wen
机构
[1] The Second Xiangya Hospital,Department of General Surgery
[2] Central South University,undefined
来源
World Journal of Surgical Oncology | / 14卷
关键词
Pancreatic cancer; Gemcitabine; Cisplatin; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 154 条
[1]  
Siegel R(2014)Cancer statistics, 2014 CA 64 9-29
[2]  
Ma J(2013)A randomized controlled trial of gemcitabine plus cisplatin versus gemcitabine alone in the treatment of metastatic pancreatic cancer Cancer Chemother Pharmacol 72 637-642
[3]  
Zou Z(2012)Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience J Gastrointest Oncol 3 326-334
[4]  
Jemal A(2011)Pancreatic cancer Lancet 378 607-620
[5]  
Chao Y(2010)Pancreatic cancer New Engl J Med 362 1605-1617
[6]  
Wu CY(2014)Polychemotherapy or gemcitabine in advanced pancreatic cancer: a meta-analysis Dig Liver Dis 46 452-459
[7]  
Wang JP(1997)Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J Clin Oncol 15 2403-2413
[8]  
Lee RC(2009)Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer J Clin Oncol 27 5513-5518
[9]  
Lee WP(2013)Cisplatin-induced non-apoptotic death of pancreatic cancer cells requires mitochondrial cyclophilin-D-p53 signaling Biochem Biophys Res Commun 437 526-531
[10]  
Li CP(1996)Synergistic interaction between cisplatin and gemcitabine in vitro Clin Cancer Res 2 521-530